Linagliptin and Metformin HCl Tablet Supplier, Manufacturer & Global Exporter in India

Linagliptin and Metformin HCl Tablet Supplier, as a trusted we provide this high-quality oral medication that works by targeting multiple pathways to control blood sugar levels and improve overall glycaemic stability. Manufactured under stringent WHO-GMP standards, our formulations ensure consistency, purity, and therapeutic reliability. The Linagliptin and Metformin HCl Tablet is a combination antidiabetic formulation developed to help manage type 2 diabetes mellitus effectively.

Our role as a reputed Linagliptin and Metformin HCl Tablet Supplier extends beyond local distribution — we cater to global markets including Asia, Africa, Latin America, and the Middle East, offering competitive pricing and assured quality. Each tablet is developed to support patients and healthcare professionals with reliable glycaemic control through dual-action pharmacology.

Composition and Mechanism of Action

Each Linagliptin and Metformin HCl Tablet combines two powerful antidiabetic agents:

• Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, increases incretin levels, enhancing insulin secretion and reducing glucagon production in a glucose-dependent manner.

• Metformin Hydrochloride, a biguanide, lowers hepatic glucose production and improves insulin sensitivity, allowing better glucose uptake by peripheral tissues.

Together, these agents complement each other, helping patients maintain blood glucose within the target range while minimizing the risk of hypoglycaemia. As a global Linagliptin and Metformin HCl Tablet Supplier, we ensure all formulations meet international pharmacopeial standards and exhibit accurate dose uniformity.

Uses and Indications

The Linagliptin and Metformin HCl Tablet is indicated for the management of type 2 diabetes mellitus in adults when diet, exercise, and monotherapy do not provide adequate glycaemic control. It can be used:

• As initial therapy in patients inadequately controlled with diet and exercise alone.

• As add-on therapy in patients already taking metformin or other glucose-lowering agents.

• As a maintenance therapy for patients stabilized on both linagliptin and metformin separately.

Our status as a reliable Linagliptin and Metformin HCl Tablet Supplier ensures that healthcare institutions, pharmacies, and distributors receive products that consistently meet therapeutic efficacy standards.

Dosage and Administration

Dosage should be individualized based on patient response and tolerance. Typically, the tablets are taken once or twice daily with meals to minimize gastrointestinal side effects. Patients should continue dietary and exercise regimens while on therapy. Being a professional Linagliptin and Metformin HCl Tablet Supplier, we ensure all dosage strengths are clearly labeled and comply with regulatory norms for clarity and safety.

Precautions

Before initiating treatment, several precautions must be observed:

• Kidney Function: Since metformin is excreted renally, kidney function should be evaluated prior to and during treatment.

• Lactic Acidosis Risk: Rare but serious lactic acidosis may occur, especially in patients with renal or hepatic impairment.

• Hypoglycaemia: Though rare, caution is required when used with insulin or sulfonylureas.

• Pregnancy & Lactation: Should be used only if clearly needed and under medical supervision.

• Alcohol Consumption: Excessive alcohol intake increases the risk of lactic acidosis.

• Surgery or Radiologic Studies: Temporary discontinuation may be advised prior to procedures requiring iodinated contrast.

As a responsible Linagliptin and Metformin HCl Tablet Supplier, we emphasize clear labeling, physician guidance, and patient education to ensure optimal and safe use.

Side Effects

Most patients tolerate Linagliptin and Metformin HCl Tablets well, but some may experience:

• Common: Nausea, diarrhea, abdominal discomfort, headache, and mild hypoglycaemia.

• Less Common: Fatigue, metallic taste, upper respiratory tract infection, or nasopharyngitis.

• Rare but Serious: Lactic acidosis (manifested by weakness, muscle pain, or breathing difficulty).

Our role as a reliable Linagliptin and Metformin HCl Tablet Supplier is to ensure pharmacovigilance, provide updated safety data, and maintain product transparency.

Why Choose Us

• WHO-GMP & ISO-certified manufacturing facilities.

• Multiple packaging options tailored to market needs.

• Strong distribution network across regulated and semi-regulated markets.

• Dedicated customer support for procurement, documentation, and logistics.

• Commitment to long-term partnerships as a trusted Linagliptin and Metformin HCl Tablet Supplier and global exporter.

Through stringent quality control and regulatory compliance, we proudly serve as your dependable Linagliptin and Metformin HCl Tablet Supplier, ensuring every dose delivers therapeutic excellence and reliability.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export  Linagliptin and Metformin HCl Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.